Sana Biotechnology (NASDAQ:SANA – Get Free Report) announced its earnings results on Monday. The company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.02, Zacks reports.
Sana Biotechnology Stock Down 20.4 %
Sana Biotechnology stock traded down $0.57 during trading on Tuesday, hitting $2.21. The stock had a trading volume of 4,141,151 shares, compared to its average volume of 2,987,484. The stock’s 50 day moving average is $3.05 and its two-hundred day moving average is $3.23. Sana Biotechnology has a 1 year low of $1.52 and a 1 year high of $10.50. The stock has a market cap of $492.31 million, a price-to-earnings ratio of -1.56 and a beta of 1.63.
Insider Buying and Selling at Sana Biotechnology
In other news, insider Fmr Llc sold 290,912 shares of the company’s stock in a transaction on Wednesday, January 8th. The shares were sold at an average price of $6.49, for a total value of $1,888,018.88. Following the transaction, the insider now owns 4,541,511 shares of the company’s stock, valued at approximately $29,474,406.39. This represents a 6.02 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 31.10% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on SANA
About Sana Biotechnology
Sana Biotechnology, Inc, a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others.
Further Reading
- Five stocks we like better than Sana Biotechnology
- How to Evaluate a Stock Before Buying
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Choose Top Rated Stocks
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
- The How and Why of Investing in Gold Stocks
- Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
Receive News & Ratings for Sana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.